Results 131 to 140 of about 6,796 (211)

Fibrodysplasia Ossificans Progressiva: Clinical and Genetic Aspects [PDF]

, 2011
Robert J Pignolo, Eileen M Shore, Frederick S Kaplan   +2 more
core   +1 more source

ACVR1 wt Allele [PDF]

, 2020
openaire   +1 more source

The HIF-1α and mTOR Pathways Amplify Heterotopic Ossification

Biomolecules
Fibrodysplasia ossificans progressiva (FOP; MIM# 135100) is an ultra-rare congenital disorder caused by gain-of-function point mutations in the Activin receptor A type I (ACVR1, also known as ALK2) gene.
Haitao Wang, Frederick S. Kaplan, Robert J. Pignolo   +2 more
doaj   +1 more source

Histone Variant H3.3: A versatile H3 variant in health and in disease [PDF]

, 2016

core   +1 more source

The Mütter Museum of the College of Physicians of Philadelphia: An introduction to its history and resources for the teaching of human developmental biology [PDF]

, 2008
Grunwald, Gerald B.
core   +4 more sources

Orosomucoid 2 promotes colorectal cancer liver metastasis by suppressing natural killer cell-mediated antitumor immunity by remodeling the serine and one-carbon metabolism pathway. [PDF]

Mol Cancer
Zhou J, He X, Xiang Z, Wang M, Xu W, Wang Y, Chen Y, Zhang T, Wang L, Mao A.   +9 more
europepmc   +1 more source

Comparison of the enzymatic and cellular profiles of clinical JAK inhibitors for the treatment of myelofibrosis. [PDF]

Blood Neoplasia
Celik H, Wass B, Zolotarjova N, Trivedi G, Margulis A, Drake K, Covington M, Laranjeira ABA, Katiyar K, Smith A, Zhang G, Macarrón R.   +11 more
europepmc   +1 more source

The role of muscle fascia in heterotopic ossification and maintenance of skeletal muscle integrity in fibrodysplasia ossificans progressiva. [PDF]

Bone
Hanson LR, Scalise KL, Esch RM, Nevo L, Goldhamer DJ.   +4 more
europepmc   +1 more source

ACVR mutation [NM_001105.4:c.774G>T (p.Arg258Ser)] in pediatric fibrodysplasia ossificans progressiva complicated by scoliosis: a case report. [PDF]

Front Pediatr
Yang F, Liu M, Pei S, Huang J, Wang H.
europepmc   +1 more source

Compound KTI-2338 Inhibits ACVR1 Receptor Signaling in Fibrodysplasia Ossificans Progressiva. [PDF]

Pharmaceutics
Rosenberg NM, Zhytnik L, Wisse LE, Botman E, Lachey JL, Eekhoff EMW, Micha D.   +6 more
europepmc   +1 more source